Skip to main content
Quest Diagnostics

Important genotyping

AccuType® CP: Importance of Genotyping

AccuType CP conveniently identifies the genetic mutation of the CYP2C19 genotypes (*2,*3,*4,*5) that cause clopidogrel resistance, and determines if a patient should be prescribed clopidogrel. It reports if patients are a poor, intermediate or extensive metabolizer of the drug clopidogrel:

Metabolizer Types Clinical Interpretation
Hyperextensive - HM Increased bleeding risk
Extensive - EM Standard clopidogrel dose recommended
Intermediate - IM Increase clopidogrel dose or consider alternate therapy
Poor - PM

Our genetic counselors can provide additional assistance with AccuType CP results interpretation. Call 1-866-GENE-INFO (1-866-436-3463).

References

  1. Gladding P, et al. Pharmacogenetics Testing for Clopidogrel Using the Rapid INFINITI Analyzer, Journal of the American College of Cardiology: Cardiovascular Interventions 2009; 2:1095-1101.
  2. Mega et al. Cytochrome P-450 Polymorphisms and Response to Clopidogrel, New England Journal of Medicine 2009; 22; 360 (4): 354-362.
  3. Simon T, et al. Genetic Determinants of Response to Clopidogrel and Cardiovascular Events. New England Journal of Medicine 2009; 360 (4): 363-375.
  4. Hulot et al, Cardiovascular Risk in Clopidogrel Treated Patients According to Cytochrome P450 2C19*2. Loss of Function Allele or Proton Pump Inhibitor Co-administration: A Systematic Meta-Analysis JACC 2010. 56(2) 134-143.
  5. Mega et al, Reduced Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients treated with Clopidogrel Predominantly for PCI: A Meta-Analysis. JAME 2010; 304 (16) 1821- 1830.

Ready to order?

See ordering and CPT codes, specimen requirements, test methodology, set-up schedule and more

Visit our test menu

Cardiovascular

Education center

Visit our Education Center for presentations, Expert Insights, and CEs

Learn more

Have questions? We're here to help

Contact us

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.